Resverlogix (TSE:RVX) Reaches New 52-Week Low at $0.05

Resverlogix Corp. (TSE:RVXGet Free Report)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as C$0.05 and last traded at C$0.05, with a volume of 1000 shares trading hands. The stock had previously closed at C$0.05.

Resverlogix Price Performance

The company has a market capitalization of C$13.74 million, a PE ratio of -0.63 and a beta of 0.69. The company’s 50 day simple moving average is C$0.06 and its 200 day simple moving average is C$0.06.

Resverlogix (TSE:RVXGet Free Report) last announced its quarterly earnings results on Monday, April 1st. The biotechnology company reported C($0.01) EPS for the quarter. On average, equities analysts forecast that Resverlogix Corp. will post -0.22 EPS for the current year.

About Resverlogix

(Get Free Report)

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.

Read More

Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with's FREE daily email newsletter.